HOME >> BIOLOGY >> NEWS
AACR applauds NCI initiative on nanotechnology

To better understand the molecular steps that result in cancer and its spread, scientists and clinicians increasingly are turning to smaller and smaller probes that not only act as microscopic sentinels, but also as tools capable of interfering with these processes.

For this reason, the American Association for Cancer Research applauds the new initiative announced today by the National Cancer Institute to harness the power of nanotechnology in the fight against cancer.

"Nanotechnology can serve as an effective complement to approaches including proteomics and bioinformatics that will become critical components in the near- and long-term progress in cancer diagnostics, treatment and prevention," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of AACR.

As outlined, the NCI Alliance for Nanotechnology in Cancer will provide $144.3 million over five years to bring together researchers, clinicians and public and private organizations to translate cancer-related nanotechnology research for the benefit of the patient. Nanotechnology refers to the interactions of cellular and molecular components and engineered materials typically clusters of atoms, molecules and molecular fragments at the most elemental level of biology. Such nanoscale objects can be useful by themselves or as part of larger devices containing multiple nanoscale objects.

The new effort is designed to enhance cross-disciplinary and cross-sector collaborations in nanotechnology, which scientists now believe is poised for prime time application.

"Engineers, physicists, chemists and material scientists will now be able to work closely with biologists and cancer researchers to create nanotechnology devices capable of probing the inner sanctum of the cell and the multifactorial process that leads to cancer and metastasis," said Lynn M. Matrisian, Ph.D., president of the AACR. "Such collaborations are essential if we are going to make the advances
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
13-Sep-2004


Page: 1 2

Related biology news :

1. AACR applauds FDA decision to create new office of oncology drug products
2. USGS director applauds FY 2001 appropriations
3. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
4. Safety of isoflavones in dietary supplements targeted by Illinois initiative
5. Homeland security initiative takes Memphis ORNL technologies to the nation
6. Virginia Center for Coal and Energy Research helps implement global climate change initiative
7. New Seascape initiative stretches from Costa Rica to Ecuador and protects key marine habitats
8. Applying results of womens health initiative study to individual patients
9. Largest brain repair initiative in MS will speed strategies to restore nerve function
10. Collaborative research initiative aims to cut drug development time in half
11. Open access initiative from the Company of Biologists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2019)... ... October 11, 2019 , ... Advanced Clinical, ... researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for Oncology. Dr. Tyan ... enhancing the already strong scientific and delivery credentials previously offered at Advanced Clinical. ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a ... attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit ... 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from ...
(Date:10/8/2019)... ... 07, 2019 , ... Imaging data sets are generated through ... projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and X-ray CT. ... a lot of research groups struggle with transforming these large and sometimes noisy ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New ... M.D., Ph.D., discussed important design factors that currently limit the success of early stage ... of clinical trials, in his talk Dr. Sherley focused on the highly ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... research in the area of high-level X-ray methods using synchrotron-produced X-rays to ... of Improved Pharma, will present “Synchrotron X-Ray Diffraction and Pair Distribution Function ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, ... the development of therapies to treat central nervous system (CNS) disorders, today ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... PhD, RD, to its Scientific Advisory Board. Dr. Holscher is an Assistant Professor ... Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, where she has ...
Breaking Biology Technology:
Cached News: